| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0006-8993(97)00096-6 |
| P698 | PubMed publication ID | 9134985 |
| P2093 | author name string | Schwarz M | |
| Pergande G | |||
| Block F | |||
| P2860 | cites work | Place navigation impaired in rats with hippocampal lesions | Q29547869 |
| Temporal profile of neuronal damage in a model of transient forebrain ischemia | Q34278838 | ||
| Selective vulnerability of the hippocampus in brain ischemia | Q36501847 | ||
| Flupirtine increases the levels of glutathione and Bc1-2 in hNT (human Ntera/D1) neurons: mode of action of the drug-mediated anti-apoptotic effect | Q41145481 | ||
| Neuronal degeneration in hippocampus and cerebellum of mutant spastic Han-Wistar rats | Q42476100 | ||
| The N-methyl-D-aspartate antagonists CGS 19755 and CPP reduce ischemic brain damage in gerbils | Q43460736 | ||
| Protection by NMDA antagonists against selective cell loss following transient ischaemia | Q43530761 | ||
| Global ischaemia: hippocampal pathology and spatial deficits in the water maze. | Q48120828 | ||
| Depression by flupirtine, a novel analgesic agent, of motor and sensory responses of the nociceptive system in the rat spinal cord | Q48184212 | ||
| The antioxidant LY231617 reduces global ischemic neuronal injury in rats | Q48290608 | ||
| Quinolinic acid lesion of the striatum induces impairment in spatial learning and motor performance in rats | Q48347045 | ||
| The non-NMDA antagonists, NBQX and GYKI 52466, protect against cortical and striatal cell loss following transient global ischaemia in the rat | Q48545756 | ||
| Spatial learning is affected by transient occlusion of common carotid arteries (2VO): comparison of behavioural and histopathological changes after '2VO' and 'four-vessel-occlusion' in rats | Q48759117 | ||
| Protection against ischemia-induced neuronal damage by the alpha 2-adrenoceptor antagonist idazoxan: influence of time of administration and possible mechanisms of action | Q48874352 | ||
| Pretreatment but not posttreatment with GYKI 52466 reduces functional deficits and neuronal damage after global ischemia in rats | Q48951360 | ||
| Memantine reduces functional and morphological consequences induced by global ischemia in rats | Q48987990 | ||
| 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a neuroprotectant for cerebral ischemia | Q49105194 | ||
| Flupirtine depresses nociceptive activity evoked in rat thalamus. | Q51769819 | ||
| Posttreatment with EPC-K1, an inhibitor of lipid peroxidation and of phospholipase A2 activity, reduces functional deficits after global ischemia in rats | Q52055278 | ||
| The antioxidant LY 231617 ameliorates functional and morphological sequelae induced by global ischemia in rats. | Q52205394 | ||
| Neuroprotective properties of the novel antiepileptic lamotrigine in a gerbil model of global cerebral ischemia. | Q52209617 | ||
| S-emopamil ameliorates ischemic brain damage in rats: histological and behavioural approaches. | Q52243195 | ||
| Role for gamma-aminobutyric acid in selective vulnerability in gerbils | Q69950543 | ||
| GABA agonist "muscimol" is neuroprotective in repetitive transient forebrain ischemia in gerbils | Q70494137 | ||
| MK-801 (dizocilpine) protects the brain from repeated normothermic global ischemic insults in the rat | Q70501475 | ||
| Flupirtine protects neurons against excitotoxic or ischemic damage and inhibits the increase in cytosolic Ca2+ concentration | Q71377073 | ||
| Flupirtine protects against ischaemic retinal dysfunction in rats | Q72110358 | ||
| Immunohistochemical evidence for flupirtine acting as an antagonist on theN-methyl-d-aspartate and homocysteic acid-induced release of GABA in the rabbit retina | Q72111867 | ||
| The triaminopyridine flupirtine prevents cell death in rat cortical cells induced by N-methyl-D-aspartate and gp120 of HIV-1 | Q72130473 | ||
| N-methyl-D-aspartate (NMDA)-mediated muscle relaxant action of flupirtine in rats | Q72498080 | ||
| Cerebroprotective effect of BW619C89 after focal or global cerebral ischaemia in the rat | Q72660431 | ||
| P433 | issue | 1-2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 279-284 | |
| P577 | publication date | 1997-04-01 | |
| P1433 | published in | Brain Research | Q4955782 |
| P1476 | title | Flupirtine reduces functional deficits and neuronal damage after global ischemia in rats | |
| P478 | volume | 754 |
| Q48223080 | Ameliorative effects of a neuroprotective agent, T-817MA, on place learning deficits induced by continuous infusion of amyloid-beta peptide (1-40) in rats |
| Q48344766 | Antioxidant properties of the triaminopyridine, flupirtine |
| Q42549147 | Antiparkinsonian and other motor effects of flupirtine alone and in combination with dopaminergic drugs |
| Q40842227 | Association of increased bcl-2 expression with rescue from tumor necrosis factor-alpha-induced cell death in the oligodendrocyte cell line OLN-93. |
| Q60952978 | Brain Distribution and Metabolism of Flupirtine, a Nonopioid Analgesic Drug with Antiseizure Effects, in Neonatal Rats |
| Q57816829 | Disease Modification in Multiple Sclerosis by Flupirtine-Results of a Randomized Placebo Controlled Phase II Trial |
| Q92376694 | Effects of a potassium channel opener on brain injury and neurologic outcomes in an animal model of neonatal hypoxic-ischemic injury |
| Q74317079 | Flupirtine and retigabine prevent L-glutamate toxicity in rat pheochromocytoma PC 12 cells |
| Q36943102 | Flupirtine as neuroprotective add-on therapy in autoimmune optic neuritis |
| Q41724627 | Flupirtine, a nonopioid centrally acting analgesic, acts as an NMDA antagonist |
| Q34322776 | Flupirtine, a re-discovered drug, revisited |
| Q33643194 | Global ischemia and behavioural deficits |
| Q54546730 | Hericium erinaceus suppresses LPS-induced pro-inflammation gene activation in RAW264.7 macrophages. |
| Q34038310 | Novel approaches in diagnosis and therapy of Creutzfeldt-Jakob disease |
| Q34747314 | Pharmacological intervention in age-associated brain disorders by Flupirtine: Alzheimer's and prion diseases |
| Q48424753 | Piperphentonamine (PPTA) attenuated cerebral ischemia-induced memory deficits via neuroprotection associated with anti-apoptotic activity |
| Q44287259 | Propofol post-conditioning induced long-term neuroprotection and reduced internalization of AMPAR GluR2 subunit in a rat model of focal cerebral ischemia/reperfusion |
| Q35092261 | Prospects for antiapoptotic drug therapy of neurodegenerative diseases |
| Q44650194 | Protective effects of methanol extract of Acori graminei rhizoma and Uncariae Ramulus et Uncus on ischemia-induced neuronal death and cognitive impairments in the rat |
| Q35872543 | The Effects of the KCNQ Openers Retigabine and Flupirtine on Myotonia in Mammalian Skeletal Muscle Induced by a Chloride Channel Blocker |
| Q41724639 | The b-wave of the electroretinogram as an index of retinal ischemia |
| Q42269178 | The indirect NMDAR inhibitor flupirtine induces sustained post-ischemic recovery, neuroprotection and angioneurogenesis. |
| Q79760113 | The neuroprotectant properties of glutamate antagonists and antiglutamatergic drugs |
| Q41860460 | The neuroprotective effect of methanol extract of gagamjungjihwan and fructus euodiae on ischemia-induced neuronal and cognitive impairment in the rat |
Search more.